Anmelden

Core IM | Internal Medicine Podcast

#136 How Did Diabetes Medications Become Obesity Meds? Beyond Journal Club on SURMOUNT-1 Trial

· 22 min

MP3

Shownotes

<p>What is the difference between semaglutide (ozempic) and tirzepatide (mounjaro) in outcomes and mechanism? How did we find out diabetes medications can help with weight loss?</p><p>Sponsors: <a href="coreimpodcast.com/post"; rel="nofollow">Post Investment: Real Estate Syndications</a> || <a href="coreimpodcast.com/hellofresh"; rel="nofollow">Hellofresh</a> </p><p><a href="coreimpodcast.com/2023/10/04/bjc-episode-2-sur…; rel="nofollow">Show Notes & Transcript</a></p><ul><li>02:08 Framework for thinking about obesity</li><li>03:42 History of obesity treatment</li><li>06:29 Gila monsters and GLP and GIP mechanisms</li><li>08:29 Story of how medications for diabetes were found to have a weight loss benefit</li><li>12:50 SURMOUNT-1 trial</li></ul><p><br></p><p>Tags: IMCore, CoreIM, primary care, cardiology, nurse practitioner, pharmacist, physician assistant</p><br /><br />Find the best disability insurance for you: patternlife.com/disability-insurance?campid=49… Sponsors:<br/>* Check out Eko: ekohealth.com<br/>* Check out FIGS and use my code FIGSRX for a great deal: wearfigs.com<br/><br/><br/>A… Inquiries: <a href='redcircle.com/brands'>https://redcircle… & Opt-Out: <a href='redcircle.com/privacy'>https://redcircl…;

Anmelden oder registrieren

Jetzt

0:00 / 0:00